Biotech

At the beginning of April, 2016, Minnesota based biotech Vascular Solutions, Inc. (NASDAQ:VASC) reported that it was withdrawing and recalling a large number of its lead product, its Guardian® II Hemostasis Valves, from the market. The recall came on the back of findings that suggested the product could leak,...

Intro & History on ABBV (NYSE:ABBV) :    In the biotech and medical marijuana arena, we think that ABBV AbbVie Inc. (NYSE ABBV) is an interesting and well known stock to keep an eye on. ABBV is a pharmaceutical development, discovery, manufacturing and sales firm based in Illinois near Chicago, and...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Fluidigm Corp (NASDAQ:FLDM) reported that Adage Capital Management has picked up 1,546,209 of common stock as of 2017-03-13. The acquisition brings the aggregate amount owned by Adage Capital Management to a total of 1,546,209 representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Axogen Inc. (NASDAQ:AXGN) reported that  Flynn James E has picked up 1,838,225 of common stock as of 2016-12-15. The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,838,225 representing...

We think Cara Therapeutics (NASDAQ: CARA), a boutique “clinical stage” biotech/biopharma firm which develops novel compounds (including cannabis derived chemicals) for neuropathic pain is worthy of a close look. Cannabis regulation has been relaxing both globally and in the United States and this influences our stance on CARA stock....